Supreme Court Explains 7 Sub-Rights that Must be Protected by State During Land Acquisition  ||  SC: Accused Can’t be Arrested by ED After Special Court has Taken Cognizance of PMLA Complaint  ||  SC: Employees Filing Writ Petitions Against Air India After its Privatisation, Not Maintainable  ||  SC: UP Anti-Conversion Law May Seem to be Violating Article 25 of Constitution of India  ||  SC: UP Anti-Conversion Law May Seem to be Violating Article 25 of Constitution of India  ||  Kerala High Court: Power to Add Charges Remains With Court, Can’t be Done at Behest of Parties  ||  Allahabad High Court: Can’t Allow Petition for Expeditious Disposal of Cases on Regular Basis  ||  SC: Can’t Consider Payment of Compensation A Factor to Reduce Sentence of Convict  ||  SC: No Need for PMLA Acc. to Fulfill S. 45 Conditions When Furnis. Bond After Appearing Before Court  ||  Plea to Terminate 30 Weeks Pregnancy Dismissed, SC Talks About Right to Life of Child in Womb    

Cipher, Ranbaxy Settle Patent Dispute with Actavis over Absorica - (06 Oct 2015)

Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a drug used to treat acne.

Tags : CIPHER   RANBAXY   ABSORICA PATENT  

Share :        

Disclaimer | Copyright 2024 - All Rights Reserved